Lyft and Uber are expected to release their earnings reports this week. Which one of them will weather the COVID-19 storm? At the time of writing, their stocks are in red.
While the company has had great gains as it works on a COVID-19 vaccine, Inovio (INO) stock fell last Friday, was down in the-premarket today but is up as trading began.
Mastercard announced a new president of its European business in the person of Mark Barnett, MA stock is 0.24% down now. The current price is $268.24.
Amazon (AMZN) stock price has fallen marginally after a great run last quarter. The tech stock could be testing support levels for a huge bull run. AWS could drive this growth.
Airlines stocks slid further on Monday after investor Warren Buffett said that Berkshire Hathaway exited its stakes in four of the largest U.S. air carriers American, United, Delta and Southwest airlines due to the coronavirus.
After Friday’s crash, Tesla (TSLA) has begun to rise in the pre-market but now is falling again.
Moderna (MRNA) stock price is up as U.S. President Donald Trump has indicated that there could be a working COVID-19 vaccine by the end of the year.
The American multinational corporation Intel is going to acquire Moovit for $1 billion. Meanwhile, Intel (INTC) is slightly down in the pre-market.
Warren Buffett’s Berkshire Hathaway refrains from any fresh buys during this market correction saying that the market is just not attractive enough to make new investments.
Following the Gilead CEO’s statement about exporting remdesivir to the U.S. hospitals, Gilead Sciences (GILD) stock is up. In the pre-market today, Gilead shares are over 3% up, trading at above $82.
Berkshire Hathaway had a record $137 billion in cash and equivalent instruments on its balance sheet at the end of Q1 2020. Meanwhile, Warren Buffett has decided to sell the airlines stocks.
Tesla (TSLA) stock lost over 10% yesterday. The fall is attributed to a series of controversial tweets from Elon Musk. In one of them, he said that TSLA stock price is too high.
Moderna is moving forward with its coronavirus vaccine. The company announced a deal with Lonza Group AG to manufacture 1 billion coronavirus vaccine doses a year. MRNA stock is up.
Apple reported revenue of $58.3 billion for its fiscal second quarter, falling below its initial Q2 guidance but surpassing Wall Street’s muted expectations. AAPL stock is down in the pre-market.
As it has become known that AstraZeneca and Oxford University are working together on a coronavirus vaccine, the AZN stock price is rising.